Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

198
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
198
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

147
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
147
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

229
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
229
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

324
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
324
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

162
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
162
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.3K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Reference-Quality NLRome for the Hexaploid Sweetpotato and Diploid Wild Relatives.

Molecular plant-microbe interactions : MPMI·2025
Same author

Unravelling novel and closely linked association signals for fat-related traits in pigs using prioritised variants from whole-genome sequence data.

Animal : an international journal of animal bioscience·2025
Same author

Reimagining physiology education with interactive content developed in H5P.

Advances in physiology education·2021
Same author

Genomic signature of successful colonization of Eurasia by the allopolyploid shepherd's purse (Capsella bursa-pastoris).

Molecular ecology·2015
Same author

Limited genomic consequences of mixed mating in the recently derived sister species pair, Collinsia concolor and Collinsia parryi.

Journal of evolutionary biology·2014
Same author

[Forced spirometry in healthy preschool children].

Anales de pediatria (Barcelona, Spain : 2003)·2009

Related Experiment Video

Updated: Nov 29, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.0K

Classification of hypertensive cardiomyopathy

M Iriarte1, N Murga, D Sagastagoitia

  • 1University of the Basque Country Institute of Cardiology, Hospital Civil de Basurto, Bilbao (Bizkaia), Spain.

European Heart Journal
|November 1, 1993
PubMed
Summary

A new classification system for hypertensive cardiomyopathy stages the disease based on heart impact from high blood pressure. This system helps identify early diastolic dysfunction and later stages of heart failure.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.0K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.4K

Related Experiment Videos

Last Updated: Nov 29, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.0K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.0K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.4K

Area of Science:

  • Cardiology
  • Hypertension Research
  • Heart Failure Studies

Background:

  • Chronic systemic arterial hypertension significantly impacts cardiac structure and function.
  • Hypertensive cardiomyopathy is a complex condition requiring a structured classification.
  • Existing classifications may not fully capture the pathophysiological spectrum.

Purpose of the Study:

  • To establish a clinical pathophysiological classification for hypertensive cardiomyopathy.
  • To stratify patients based on the degree of cardiac involvement due to hypertension.
  • To provide a framework for understanding disease progression and guiding treatment.

Main Methods:

  • Classification based on clinical presentation, echocardiography (left ventricular hypertrophy, ejection fraction, ventricular volumes), Doppler mitral inversion, and gamma scintigraphy.
  • Stratification into four degrees (I-IV) with subgroups (IIA/IIB, IIIA/IIIB) based on specific cardiac parameters.
  • Utilizing diagnostic criteria such as E/A ratio, peak filling rate, mass/volume index, and New York Heart Association (NYHA) functional class.

Main Results:

  • Degree I: Asymptomatic with diastolic dysfunction (normal ejection fraction).
  • Degree II: Asymptomatic/mildly symptomatic with left ventricular hypertrophy (stratified by oxygen uptake).
  • Degree III: Congestive heart failure with preserved ejection fraction (subdivided by hypertrophy index).
  • Degree IV: Depressed contractility, reduced ejection fraction (<50%), and increased ventricular volumes.

Conclusions:

  • The proposed classification effectively categorizes hypertensive cardiomyopathy based on pathophysiological changes.
  • This staging system differentiates early diastolic dysfunction from advanced heart failure.
  • It provides a basis for further research and clinical management of hypertensive heart disease.